Rapid Diagnostics Market by Application and Geography - Forecast and Analysis 2022-2026
| Published: Apr 2022 | Pages: 148 | SKU: IRTNTR73064 |
The rapid diagnostics market share is expected to increase by USD 12.74 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.58%.
This rapid diagnostics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers rapid diagnostics market segmentations by application (blood glucose, infectious disease, cardiometabolic, pregnancy and fertility, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The rapid diagnostics market report also offers information on several market vendors, including Abbott Laboratories, Atomo Diagnostics Ltd., Becton Dickinson and Co., bioMerieux SA, Cardinal Health Inc., Chembio Diagnostics Inc., DAAN Gene Co. Ltd., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GlySens Inc., Johnson and Johnson, Meridian Bioscience Inc., NanoRepro AG, Quidel Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech Plc, Wuhan EasyDiagnosis Biomedicine Co. Ltd, and OraSure Technologies Inc. among others.
What will the Rapid Diagnostics Market Size be During the Forecast Period?
Download the Free Report Sample to Unlock the Rapid Diagnostics Market Size for the Forecast Period and Other Important Statistics
Rapid Diagnostics Market: Key Drivers, Trends, and Challenges
The increasing incidence of chronic and infectious diseases is notably driving the rapid diagnostics market growth, although factors such as the high cost of rapid diagnostic products may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the rapid diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Rapid Diagnostics Market Driver
The increasing incidence of chronic and infectious diseases is one of the key drivers supporting the rapid diagnostics market growth. There is growing disposable income among middle-class families due to urbanization which is leading to the adoption of unhealthy lifestyles and ultimately causes chronic diseases such as cardiovascular diseases and diabetes. In 2019, according to CDC, approximately 92.1 million individuals in the US had one type of cardiovascular disease. Meanwhile, there is also a high burden of infectious diseases in developing countries where the healthcare infrastructure and healthcare awareness are still in the developing phase. Infectious diseases such as malaria, influenza, and others are some of the leading causes of hospital admission. In view of all these factors, the rapid diagnostics market will have a positive impact during the forecast period.
Key Rapid Diagnostics Market Trend
The growing presence of OEMs is one of the key rapid diagnostics market trends that is contributing to the market growth. The OEM provides equipment to the manufacturers that develop, distribute, and sell the final furnished goods. Generally, OEM develops certain components of the products. However, sometimes, it may manufacture a complete device. The OEMs are working with contract manufacturing organizations (CMOs) due to the increasing number of combination products such as drug delivery and smart devices. Thus, there is a growing focus on forwarding integration by the OMEs involved in providing diagnostics components. These initiatives will propel the rapid diagnostics market growth during the forecast period.
Key Rapid Diagnostics Market Challenge
The high cost of rapid diagnostic products is one of the factors hindering the rapid diagnostics market growth. For instance, NIH conducted a comparison study between the cost of rapid molecular tests and conventional diagnostics for the detection of tuberculosis in South Africa. The result of the study was Xpert MTB/RIF Assay, a tool to diagnose tuberculosis cost around $12-$15/ sample and MTBDRplus line probe assay costs around $22-$24/sample which are slightly high compared to conventional automated liquid culture-based methods that cost around $14-$16/sample. Moreover, the cost of Xpert and MTBDRplus was mostly influenced by the cost of consumables. Therefore, the high cost of analyzers, assays, and related frequently used consumables create budget constraints for end-users and patients, which may hinder the market growth due to the low adoption of high-priced diagnostic products.
This rapid diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global rapid diagnostics market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the rapid diagnostics market during the forecast period.
Who are the Major Rapid Diagnostics Market Vendors?
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Atomo Diagnostics Ltd.
- Becton Dickinson and Co.
- bioMerieux SA
- Cardinal Health Inc.
- Chembio Diagnostics Inc.
- DAAN Gene Co. Ltd.
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- GlySens Inc.
- Johnson and Johnson
- Meridian Bioscience Inc.
- NanoRepro AG
- Quidel Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc
- Wuhan EasyDiagnosis Biomedicine Co. Ltd
- OraSure Technologies Inc.
This statistical study of the rapid diagnostics market encompasses successful business strategies deployed by the key vendors. The rapid diagnostics market is fragmented and the vendors are deploying growth strategies such as product development and expanding their reach to other regions to compete in the market.
Product Insights and News
- Abbott Laboratories - Under the diagnostic products segment, the company focuses on core laboratory, molecular solutions, point of care solutions, and rapid diagnostics
- Abbott Laboratories - The company offers rapid diagnostics that provides fast, accurate and reliable test results is vital in emergency rooms, critical care centers and other situations where treatment decisions need to be made quickly.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The rapid diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Rapid Diagnostics Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the rapid diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Which are the Key Regions for Rapid Diagnostics Market?
For more insights on the market share of various regions Request for a FREE sample now!
38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for the rapid diagnostics market in North America. Market growth in this region will be slower than the growth of the market in Asia.
The increasing awareness among individuals for healthcare government interventions to reduce the risk of various chronic illnesses and infectious diseases will facilitate the rapid diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The growth of the rapid diagnostics market had been be positively impacted in 2020 due to the rapid spread of the COVID-19 pandemic. Moreover, the evolution of the coronavirus across the world would further drive the growth of the market in the region during the forecast period.
What are the Revenue-generating Application Segments in the Rapid Diagnostics Market?
To gain further insights on the market contribution of various segments Request for a FREE sample
The rapid diagnostics market share growth by the blood glucose segment will be significant during the forecast period. Blood glucose testing accounted for the largest share in the global rapid diagnostics market, and it will grow at a moderate growth rate during the forecast period. The increasing prevalence of diabetes cases in both the younger and older population is growing the demand for blood glucose testing products in the market. The increasing number of diabetes cases among the younger and older population and an increasing number of new diabetes cases will increase the market opportunity for blood glucose testing. Also, the growing awareness regarding effective management of diabetes, government initiatives, the presence of reimbursement in a few developed countries, and an increasing number of product launches will boost the rapid diagnostics market growth during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the rapid diagnostics market size and actionable market insights on post COVID-19 impact on each segment.
|
Rapid Diagnostics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.58% |
|
Market growth 2022-2026 |
$ 12.74 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
7.25 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 38% |
|
Key consumer countries |
US, Canada, Germany, France, Japan, and China |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
Abbott Laboratories, Atomo Diagnostics Ltd., Becton Dickinson and Co., bioMerieux SA, Cardinal Health Inc., Chembio Diagnostics Inc., DAAN Gene Co. Ltd., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GlySens Inc., Johnson and Johnson, Meridian Bioscience Inc., NanoRepro AG, Quidel Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech Plc, Wuhan EasyDiagnosis Biomedicine Co. Ltd, and OraSure Technologies Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Rapid Diagnostics Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive rapid diagnostics market growth during the next five years
- Precise estimation of the rapid diagnostics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the rapid diagnostics industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of rapid diagnostics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
- 5.1 Market segments
- Exhibit 24: Chart on Application - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
- 5.2 Comparison by Application
- Exhibit 26: Chart on Comparison by Application
- Exhibit 27: Data Table on Comparison by Application
- 5.3 Blood glucose - Market size and forecast 2021-2026
- Exhibit 28: Chart on Blood glucose - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Blood glucose - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Blood glucose - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Blood glucose - Year-over-year growth 2021-2026 (%)
- 5.4 Infectious disease - Market size and forecast 2021-2026
- Exhibit 32: Chart on Infectious disease - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Infectious disease - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Infectious disease - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Infectious disease - Year-over-year growth 2021-2026 (%)
- 5.5 Cardiometabolic - Market size and forecast 2021-2026
- Exhibit 36: Chart on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Cardiometabolic - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Cardiometabolic - Year-over-year growth 2021-2026 (%)
- 5.6 Pregnancy and fertility - Market size and forecast 2021-2026
- Exhibit 40: Chart on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
- Exhibit 41: Data Table on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Chart on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)
- 5.7 Others - Market size and forecast 2021-2026
- Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
- 5.8 Market opportunity by Application
- Exhibit 48: Market opportunity by Application ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 50: Chart on Market share by geography 2021-2026 (%)
- Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 52: Chart on Geographic comparison
- Exhibit 53: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.9 Japan - Market size and forecast 2021-2026
- Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.10 Germany - Market size and forecast 2021-2026
- Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 France - Market size and forecast 2021-2026
- Exhibit 90: Chart on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 91: Data Table on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 92: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 93: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.13 Market opportunity by geography
- Exhibit 94: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 95: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 96: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 97: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 98: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 99: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 100: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 101: Abbott Laboratories - Overview
- Exhibit 102: Abbott Laboratories - Business segments
- Exhibit 103: Abbott Laboratories - Key news
- Exhibit 104: Abbott Laboratories - Key offerings
- Exhibit 105: Abbott Laboratories - Segment focus
- 10.4 Atomo Diagnostics Ltd.
- Exhibit 106: Atomo Diagnostics Ltd. - Overview
- Exhibit 107: Atomo Diagnostics Ltd. - Product / Service
- Exhibit 108: Atomo Diagnostics Ltd. - Key offerings
- 10.5 Becton Dickinson and Co.
- Exhibit 109: Becton Dickinson and Co. - Overview
- Exhibit 110: Becton Dickinson and Co. - Business segments
- Exhibit 111: Becton Dickinson and Co. - Key news
- Exhibit 112: Becton Dickinson and Co. - Key offerings
- Exhibit 113: Becton Dickinson and Co. - Segment focus
- 10.6 bioMerieux SA
- Exhibit 114: bioMerieux SA - Overview
- Exhibit 115: bioMerieux SA - Business segments
- Exhibit 116: bioMerieux SA - Key offerings
- Exhibit 117: bioMerieux SA - Segment focus
- 10.7 Cardinal Health Inc.
- Exhibit 118: Cardinal Health Inc. - Overview
- Exhibit 119: Cardinal Health Inc. - Business segments
- Exhibit 120: Cardinal Health Inc. - Key news
- Exhibit 121: Cardinal Health Inc. - Key offerings
- Exhibit 122: Cardinal Health Inc. - Segment focus
- 10.8 Chembio Diagnostics Inc.
- Exhibit 123: Chembio Diagnostics Inc. - Overview
- Exhibit 124: Chembio Diagnostics Inc. - Product / Service
- Exhibit 125: Chembio Diagnostics Inc. - Key offerings
- 10.9 Danaher Corp.
- Exhibit 126: Danaher Corp. - Overview
- Exhibit 127: Danaher Corp. - Business segments
- Exhibit 128: Danaher Corp. - Key news
- Exhibit 129: Danaher Corp. - Key offerings
- Exhibit 130: Danaher Corp. - Segment focus
- 10.10 F. Hoffmann La Roche Ltd.
- Exhibit 131: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 132: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 133: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 134: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 135: F. Hoffmann La Roche Ltd. - Segment focus
- 10.11 Johnson and Johnson
- Exhibit 136: Johnson and Johnson - Overview
- Exhibit 137: Johnson and Johnson - Business segments
- Exhibit 138: Johnson and Johnson - Key news
- Exhibit 139: Johnson and Johnson - Key offerings
- Exhibit 140: Johnson and Johnson - Segment focus
- 10.12 Siemens Healthineers AG
- Exhibit 141: Siemens Healthineers AG - Overview
- Exhibit 142: Siemens Healthineers AG - Business segments
- Exhibit 143: Siemens Healthineers AG - Key news
- Exhibit 144: Siemens Healthineers AG - Key offerings
- Exhibit 145: Siemens Healthineers AG - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 146: Inclusions checklist
- Exhibit 147: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 148: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 149: Research methodology
- Exhibit 150: Validation techniques employed for market sizing
- Exhibit 151: Information sources
- 11.5 List of abbreviations
- Exhibit 152: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
rapid diagnostics market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis